Morgan Stanley lowered the firm’s price target on Torrid (CURV) to $1.01 from $1.10 and keeps an Underweight rating on the shares. Product mis-execution drove Torrid’s sizeable Q3 miss and third consecutive FY guidance cut, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CURV:
- Torrid price target lowered to $2 from $3 at Telsey Advisory
- Cautious Hold Rating for Torrid Holdings Amid Sales Shortfall and Strategic Challenges
- Torrid price target lowered to $2 from $6 at BofA
- Torrid Holdings: Strategic Measures and Store Optimization Drive Buy Rating Amidst Expected Sales Recovery by 2026
- Torrid Holdings Reports Q3 2025 Financial Results